Jim Connolly work email
- Valid
- Valid
- Valid
Jim Connolly personal email
- Valid
Jim Connolly phone numbers
Currently seeking advisory, Board or consulting roles with early, development or commercial stage pharma/biotech organizations. Highly respected and successful leader with a functionally and geographically broad 30+ year track record, including a demonstrated ability to build and/or transform various operations and products into top performing and high-growth businesses and brands. Proven leadership skills ranging from CEO and Board Director of multiple biotech organizations to President/General Manager of Global business and major country affiliate. Strong P&L focus with the ability to leverage new and existing product opportunities, R&D, manufacturing and business development in order to assure a broad range of revenue and profit opportunities. Extensive global and U.S. product launch experience, including Prevnar family, Enbrel and Effexor XR. Significant fund raising and business development experience across wide range of sources and deal types. Successful track record across wide array of organization types (large Pharma to virtual biotech) and numerous specialty and primary care disease and therapeutic areas. Spent 24 years at Wyeth (now Pfizer) in series of general management, commercial and finance roles including EVP and GM, Wyeth Vaccines and President and GM, Wyeth Canada. More recently served as CEO of two biotech companies (Aeras and Tivorsan) and board director and/or advisor to various life science and investment organizations.
-
ValnevaWayne, Pa, Us
-
DirectorValneva Jun 2022 - PresentSaint-Herblain, Pays De La Loire, FrValneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need.
-
DirectorInternational Aids Vaccine Initiative (Iavi) Oct 2018 - PresentNew York, Ny, UsIAVI is a nonprofit scientific organization dedicated to addressing urgent, unmet global health challenges including HIV and tuberculosis. -
Advisor, Consultant And Board MemberJe Connolly Consulting Mar 2013 - PresentCurrently serve on the Board of Directors for several organizations, including Valneva, IAVI and Covenant House PA. Formerly served on Aeras, PaxVax, Vaxess Technologies, Tivorsan and Ambulatus Robotics boards. Provide broad based consulting and advisory services to a variety of Pharma, biotech, vaccine and investment organizations covering commercial, corporate/business development, M&A, corporate strategy, product launches, fund raising, business start-up, organizational development and other areas. While serving on various boards, helped facilitate efforts to secure significant capital via VC/PE fund raising, PRV sale, company sale and other sources.
-
DirectorVaxess Technologies Sep 2013 - Jul 2019Boston, Ma, Us -
DirectorPaxvax Apr 2014 - Oct 2018PaxVax is a specialty vaccine company focused on travelers and biodefense markets with a social mission to ensure global access to its vaccines. Supported efforts that resulted in securing additional capital (debt and PE financing and PRV sale) and sale of company.
-
DirectorAeras Aug 2010 - Jun 2018Aeras is a nonprofit biotech organization focused on the development of vaccines and biologics for TB and other neglected diseases. Helped facilitate efforts to merge remaining Aeras operations into IAVI and subsequently joined IAVI board.
-
President And CeoAeras Aug 2010 - Jun 2013Full responsibility for non-profit, fully integrated biotech organization with $50 mm + R&D budget and over 160 employees in US, Africa and China. Stabilized and transformed organization - secured funding in excess of $275 mm - advanced and strengthened overall product portfolio and key partnerships.
-
CeoTivorsan Pharmaceuticals Aug 2015 - Dec 2016Overall responsibility for development stage biotech company developing novel approaches to treating serious orphan neuromuscular diseases, including muscular dystrophy and ALS. Secured financing to support operations and development efforts and advanced lead candidate to IND-track. -
AdvisorCrossover Healthcare Fund Nov 2013 - Dec 2016Crossover Healthcare Fund is a hedge fund with a strategic focus on financing for smaller capitalization healthcare companies. The fund engages in transaction based direct investing on a opportunistic basis through privately negotiated equity, equity-linked or credit related investments.
-
Exec Vp & Gm, Wyeth VaccinesWyeth Pharmaceuticals Nov 2004 - Oct 2009New York, New York, UsOverall responsibility for Wyeth's (now Pfizer's) global vaccines business. Strengthened and rebuilt vaccines business into one of the top four global manufacturers, increasing sales from $800 mm to over $3 billion. Developed and implemented long-term business plan that resulted in strengthened commercial organization, improved R&D pipeline and expanded manufacturing network. During this period, also co-led company-wide restructuring program that resulted in identified savings in excess of $1.5 billion. -
President & Gm, Wyeth CanadaWyeth Pharmaceuticals Nov 2002 - Oct 2004New York, New York, UsFull responsibility for country P&L and operations of 4th largest Wyeth affiliate with an employee base of over 1800, including manufacturing and R&D. Transformed historically flat, stagnant business by maximizing new and existing product opportunities. Grew sales from under $300 mm to over $650 mm and achieved #1 market share position for all key promoted brands including Effexor XR, Prevnar, Enbrel, Alesse and Premarin. Attained position as "top 50 Employer" in Canada.
-
Vice President, Sales & MarketingWyeth Pharmaceuticals Feb 2001 - Oct 2002New York, New York, Us
-
Various PositionsWyeth Pharmaceuticals Jul 1986 - Jan 2001New York, New York, Us
Jim Connolly Skills
Jim Connolly Education Details
-
Washington University In St. LouisFinance -
School Name:
Frequently Asked Questions about Jim Connolly
What company does Jim Connolly work for?
Jim Connolly works for Valneva
What is Jim Connolly's role at the current company?
Jim Connolly's current role is Board Director and Advisor.
What is Jim Connolly's email address?
Jim Connolly's email address is je****@****ail.com
What is Jim Connolly's direct phone number?
Jim Connolly's direct phone number is +161065*****
What schools did Jim Connolly attend?
Jim Connolly attended Washington University In St. Louis, School Name:.
What skills is Jim Connolly known for?
Jim Connolly has skills like Vaccines, Pharmaceutical Industry, Biotechnology, Biopharmaceuticals, Infectious Diseases, Clinical Development, Technology Transfer, Leadership, Pharmaceutical Sales, Strategic Planning, Pharmaceutics, Cross Functional Team Leadership.
Who are Jim Connolly's colleagues?
Jim Connolly's colleagues are Mahdi Niroumand Sarvandani, Anca Tautan, Christopher Gribbon, Sofia Sundberg Örtegren, Jeannine Walega, Lina Hallin, Linda Gidlöf.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial